Cognos Therapeutics
  • ABOUT
    • MISSION
    • BOARD of DIRECTORS
    • MANAGEMENT TEAM
    • IP MANAGEMENT
    • CLINICAL ADVISORY BOARD
    • REGULATORY AND COMPLIANCE
  • CLINICAL RELEVANCE
    • FOURTH MODALITY
  • PUBLICATIONS
  • NEWS
  • SHAREHOLDER PORTAL
    • SHAREHOLDER INFORMATION
  • CONTACT
Select Page
Dr. Susan Alpert, MD, PhD, Joins Cognos Therapeutics  as Lead Regulatory Consultant

Dr. Susan Alpert, MD, PhD, Joins Cognos Therapeutics as Lead Regulatory Consultant

by cognosadminteam | Feb 27, 2019 | News

27 FEBRUARY, 2019 Dr. Susan Alpert, MD, PhD, Joins Cognos Therapeutics as Lead Regulatory Consultant Dr. Susan Alpert, MD, PhD, has been named Lead Regulatory Consultant for Cognos Therapeutics, Inc. Dr. Alpert is considered one of the top U.S. regulatory ­­­experts....

Recent Posts

  • Cognos Therapeutics, Inc. To Be Publicly Listed On Nasdaq
  • Labroot’s Report Focuses on the Need To Develop Better Methods To Deliver Therapeutics to the Brain
  • Cognos Co-Founder and CIO Josh Shachar Discusses The Evolution of the Cognos Vision
  • Cognos Engages Maxim Group for Investment Banking and Financial Advisory Services
  • Cognos Announces Addition of New Clean Room To Expand Its Development Capabilites.

Recent Comments

    Archives

    • January 2023
    • January 2022
    • November 2021
    • October 2021
    • February 2019
    • January 2018
    • July 2017
    • September 2016
    • March 2015

    Categories

    • News

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Cognos Therapeutics, Inc.

    10604 S La Cienega Blvd.
    Inglewood, CA 90304
    T: 310-641-2700
    E: info@cognosthx.com

    ADDITIONAL INFO

    Privacy Policy
    Terms of Use
    • Facebook
    • Twitter
    • Instagram
    • RSS

    Designed by Elegant Themes | Powered by WordPress